XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 30, 2023
Jul. 31, 2022
Cash flows from operating activities:    
Net (loss) income $ (411,420) $ 89,644
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization 46,565 14,998
Amortization of right-of-use assets 3,282 2,302
Investment impairments and credit loss reserves, net 260 (405)
Accretion of deferred financing costs and debt discount 3,103 241
Write-off of deferred financing costs and debt discount 771 0
Deferred income taxes 50,542 261
Share-based compensation 21,803 24,143
Gain on disposition of business operations and assets (17) (17,978)
Equity method loss (income) 19 (307)
Corporate-owned life insurance, net 3,212 831
Goodwill impairment 279,555 0
Amortization of inventory step-up 3,314 0
Changes in assets and liabilities:    
Accounts receivable, net 2,725 402
Inventories 22,094 (15)
Other assets (11,179) 2,836
Accounts payable (37,730) 5,676
Accrued liabilities (71,211) 7,230
Other liabilities (7,680) (2,530)
Net cash (used in) provided by operating activities (101,992) 127,329
Cash flows from investing activities:    
Proceeds from sales of property, plant and equipment 42 0
Purchase of property, plant and equipment (20,897) (15,583)
Proceeds from sale of investments 0 2,275
Purchase of investments (930) (3,288)
Purchase of intangibles (292) 0
Proceeds from sale of business, net of cash disposed 0 26,812
Proceeds from corporate-owned life insurance 2,500 2,676
Premiums paid for corporate-owned life insurance 0 (2,676)
Net cash (used in) provided by investing activities (19,577) 10,216
Cash flows from financing activities:    
Proceeds from revolving line of credit 60,000 10,000
Payments of revolving line of credit 0 (10,000)
Payments of term loans (11,187) 0
Deferred financing costs (11,671) 0
Payments for employee share-based compensation payroll taxes (2,415) (5,616)
Proceeds from exercise of stock options 0 620
Repurchase of common stock 0 (50,000)
Net cash provided by (used in) financing activities 34,727 (54,996)
Effect of foreign exchange rate changes on cash and cash equivalents (756) 0
Net (decrease) increase in cash and cash equivalents (87,598) 82,549
Cash and cash equivalents at beginning of period 235,510 279,601
Cash and cash equivalents at end of period 147,912 362,150
Supplemental disclosure of cash flow information:    
Interest paid 40,912 1,931
Income taxes paid 15,612 5,375
Non-cash investing and financing activities:    
Accounts payable related to capital expenditures $ 1,640 $ 3,384